In this episode of the Doc Is In, we had the pleasure of hosting Dr Stephanie Ricci, a highly esteemed female surgical oncologist specializing in Gynecologic Oncology. Join us as Dr Ricci navigates us through both the Dostarlimab and Pembrolizumab clinical trials, using her wealth of experience to unravel the science behind these clinical trials and discuss their implications for patients and health professionals alike. So, whether you’re a medical professional seeking to stay ahead in your field or a curious individual wanting to learn more, prepare to be educated and inspired by Dr Ricci’s captivating exploration of the latest peerreviewed clinical trials shaping the future of advanced endometrial cancer management.

https://www.nejm.org/doi/full/10.1056...

https://www.nejm.org/doi/full/10.1056...

To refer a patient https://www.clevelandclinicabudhabi.a...